426 related articles for article (PubMed ID: 25961923)
1. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response.
Mancini F; Pieroni L; Monteleone V; Lucà R; Fici L; Luca E; Urbani A; Xiong S; Soddu S; Masetti R; Lozano G; Pontecorvi A; Moretti F
Oncogene; 2016 Jan; 35(2):228-40. PubMed ID: 25961923
[TBL] [Abstract][Full Text] [Related]
2. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
[TBL] [Abstract][Full Text] [Related]
3. Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.
Nardinocchi L; Puca R; Givol D; D'Orazi G
FEBS Lett; 2010 Oct; 584(19):4253-8. PubMed ID: 20849851
[TBL] [Abstract][Full Text] [Related]
4. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.
He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
[TBL] [Abstract][Full Text] [Related]
5. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
6. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.
Winter M; Sombroek D; Dauth I; Moehlenbrink J; Scheuermann K; Crone J; Hofmann TG
Nat Cell Biol; 2008 Jul; 10(7):812-24. PubMed ID: 18536714
[TBL] [Abstract][Full Text] [Related]
7. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
Rinaldo C; Prodosmo A; Mancini F; Iacovelli S; Sacchi A; Moretti F; Soddu S
Mol Cell; 2007 Mar; 25(5):739-50. PubMed ID: 17349959
[TBL] [Abstract][Full Text] [Related]
8. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.
Cecchinelli B; Lavra L; Rinaldo C; Iacovelli S; Gurtner A; Gasbarri A; Ulivieri A; Del Prete F; Trovato M; Piaggio G; Bartolazzi A; Soddu S; Sciacchitano S
Mol Cell Biol; 2006 Jun; 26(12):4746-57. PubMed ID: 16738336
[TBL] [Abstract][Full Text] [Related]
9. How cells switch HIPK2 on and off.
Sombroek D; Hofmann TG
Cell Death Differ; 2009 Feb; 16(2):187-94. PubMed ID: 18974774
[TBL] [Abstract][Full Text] [Related]
10. MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.
Petroni M; Veschi V; Prodosmo A; Rinaldo C; Massimi I; Carbonari M; Dominici C; McDowell HP; Rinaldi C; Screpanti I; Frati L; Bartolazzi A; Gulino A; Soddu S; Giannini G
Mol Cancer Res; 2011 Jan; 9(1):67-77. PubMed ID: 21173028
[TBL] [Abstract][Full Text] [Related]
11. MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage.
Di Conza G; Mancini F; Buttarelli M; Pontecorvi A; Trimarchi F; Moretti F
Cell Cycle; 2012 Feb; 11(4):749-60. PubMed ID: 22374672
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
13. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway.
Mancini F; Di Conza G; Pellegrino M; Rinaldo C; Prodosmo A; Giglio S; D'Agnano I; Florenzano F; Felicioni L; Buttitta F; Marchetti A; Sacchi A; Pontecorvi A; Soddu S; Moretti F
EMBO J; 2009 Jul; 28(13):1926-39. PubMed ID: 19521340
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity.
Giglio S; Mancini F; Pellegrino M; Di Conza G; Puxeddu E; Sacchi A; Pontecorvi A; Moretti F
Oncogene; 2010 Nov; 29(44):5935-45. PubMed ID: 20697359
[TBL] [Abstract][Full Text] [Related]
15. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
16. Interplay between Mdm2 and HIPK2 in the DNA damage response.
Zhang XP; Liu F; Wang W
J R Soc Interface; 2014 Jul; 11(96):. PubMed ID: 24829283
[TBL] [Abstract][Full Text] [Related]
17. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
[TBL] [Abstract][Full Text] [Related]
18. Autoregulatory control of the p53 response by Siah-1L-mediated HIPK2 degradation.
Calzado MA; de la Vega L; Muñoz E; Schmitz ML
Biol Chem; 2009 Oct; 390(10):1079-83. PubMed ID: 19642869
[TBL] [Abstract][Full Text] [Related]
19. Src kinase modulates the apoptotic p53 pathway by altering HIPK2 localization.
Polonio-Vallon T; Kirkpatrick J; Krijgsveld J; Hofmann TG
Cell Cycle; 2014; 13(1):115-25. PubMed ID: 24196445
[TBL] [Abstract][Full Text] [Related]
20. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
